公司資料
Artivion 股價、新聞與催化劑
- 股票代碼:
- AORT
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
28.32 USD (-2.81%)
收盤價
最後更新: 2026年8月17日
991M USD
市值
股價為何變動
As of Aug 17, 2026, AORT closed down 2.81% at $28.32. No new same-company headline was identified in the current news window.
公司概覽
Aortic-Disease Technologies
Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease.
Surgical Products
The company supplies aortic stent grafts, surgical adhesives, mechanical heart valves and preserved cardiac and vascular tissues. These products support both open and hybrid procedures.
Endovascular Expansion
Artivion exercised its option to acquire Endospan, developer of the FDA-approved NEXUS Aortic Arch System. The transaction would expand Artivion into endovascular treatment of aortic-arch disease alongside its existing surgical portfolio.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。